A Nomogram for Predicting Survival in Advanced Non-Small-Cell Lung Carcinoma Patients: A Population-Based Study

Abstract Non-small-cell lung cancer (NSCLC) remains the most common malignant cancer. We identified 43140 advanced NSCLC patients from the SEER database to develop and validate a new prognostic model. The prognostic performance was evaluated by P value, concordance index, net reclassification index, integrated discrimination improvement, and decision curve analysis. The following variables were contained in the final prognostic model: age, sex, race, TNM stage, and grade and treatment options. Compared to the AJCC staging system, this prognostic model is conducive to the implementation of individualized clinical treatment schemes and can be an important part of the precise medical care of NSCLC tumors.

[1]  Luchen Yang,et al.  Second Malignant Tumors and Non-Tumor Causes of Death for Patients With Penile Cancer During Their Survivorship , 2022, Cancer control : journal of the Moffitt Cancer Center.

[2]  L. Tang,et al.  A prognostic model for elderly patients with squamous non-small cell lung cancer: a population-based study , 2020, Journal of Translational Medicine.

[3]  J. Samet,et al.  Trends in the Age of Cigarette Smoking Initiation Among Young Adults in the US From 2002 to 2018 , 2020, JAMA network open.

[4]  P. Ji,et al.  A nomogram from the SEER database for predicting the prognosis of patients with non-small cell lung cancer. , 2020, The international journal of biochemistry & cell biology.

[5]  Changhui Wang,et al.  The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study , 2020, BMC Cancer.

[6]  Xianming Fan,et al.  The Positive Lymph Node Ratio Predicts Survival in T1−4N1−3M0 Non-Small Cell Lung Cancer: A Nomogram Using the SEER Database , 2020, Frontiers in Oncology.

[7]  Xianming Fan,et al.  Construction of a Nomogram After Using Propensity Score Matching to Reveal the Prognostic Benefit of Tumor Resection of Stage IV M1a Nonsmall Cell Lung Cancer Patients , 2020, Cancer investigation.

[8]  C. D. Dela Cruz,et al.  Lung Cancer 2020: Epidemiology, Etiology, and Prevention. , 2020, Clinics in chest medicine.

[9]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[10]  Xianming Fan,et al.  A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study , 2019, Oncology letters.

[11]  Xuan-Qi Zheng,et al.  Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study. , 2019, Translational lung cancer research.

[12]  G. Jiang,et al.  The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis , 2019, Clinical & Experimental Metastasis.

[13]  John Muschelli,et al.  ROC and AUC with a Binary Predictor: a Potentially Misleading Metric , 2019, Journal of Classification.

[14]  J. Shang,et al.  Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients , 2019, Journal of Cancer Research and Clinical Oncology.

[15]  E. Steyerberg,et al.  Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators. , 2018, European urology.

[16]  Jianqing Deng,et al.  Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer , 2018, Cancer management and research.

[17]  M. Painho,et al.  A geographically weighted regression approach to investigate air pollution effect on lung cancer: A case study in Portugal. , 2018, Geospatial health.

[18]  S. Rathod,et al.  Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment. , 2018, Lung cancer.

[19]  Shidan Wang,et al.  Development and Validation of a Nomogram Prognostic Model for SCLC Patients , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  Emily C. O'Brien,et al.  Application of net reclassification index to non-nested and point-based risk prediction models: a review. , 2018, European heart journal.

[21]  B. Zhivotovsky,et al.  Cell death-based treatment of lung adenocarcinoma , 2018, Cell Death & Disease.

[22]  F. Askin,et al.  Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. , 2017, Seminars in cancer biology.

[23]  Jie He,et al.  Epidemiology of Lung Cancer. , 2016, Surgical oncology clinics of North America.

[24]  Hassan Lemjabbar-Alaoui,et al.  Lung cancer: Biology and treatment options. , 2015, Biochimica et biophysica acta.

[25]  J. Austin,et al.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  G. Warren,et al.  Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions. , 2015, Translational lung cancer research.

[27]  Li Zhang,et al.  Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Perez-soler,et al.  Targeting Angiogenesis in Squamous Non-Small Cell Lung Cancer , 2014, Drugs.

[29]  Ching-Yuan Cheng,et al.  Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer Registry , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[30]  R. Hiatt,et al.  Incidence of Non–Small-Cell Lung Cancer among California Hispanics According to Neighborhood Socioeconomic Status , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  Vincenzo Valentini,et al.  Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Noelle Foreshaw.  Options… , 2010, The Resurrection of Jesus.

[33]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[34]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[35]  M. Feith,et al.  Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World , 2001, Annals of surgery.

[36]  Nicholas J Schork,et al.  Artificial Intelligence and Personalized Medicine. , 2019, Cancer treatment and research.